A detailed history of New Millennium Group LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, New Millennium Group LLC holds 46 shares of NVO stock, worth $4,019. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46
Previous 46 -0.0%
Holding current value
$4,019
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$122.71 - $146.91 $5,644 - $6,757
46 New
46 $6,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $2,091 - $4,589
23 Added 100.0%
46 $4,000
Q4 2022

Feb 07, 2023

BUY
$102.55 - $135.33 $2,358 - $3,112
23 New
23 $3,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track New Millennium Group LLC Portfolio

Follow New Millennium Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Millennium Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Millennium Group LLC with notifications on news.